Semaglutide injection is available under two brand names: Ozempic (approved for type 2 diabetes) and Wegovy (approved for weight loss and heart disease prevention), manufactured by Novo Nordisk
(7) These smaller peptides have been posited to bind with a low affinity to the GPR54 receptors and possibly stimulate calcium mobilization, arachidonic acid release, and extracellular protein kinase phosphorylation
Caught in the act: the crystal structure of cleaved cathepsin L bound to the active site of Cathepsin L
GLP-1 medications are FDA-approved for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater alongside at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol
European journal of pharmacology , 660 (1), 1320
Please discuss this with your doctor